ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly EPS (Basic) of -$1.09 for Q1 2026, up 41.18% YoY from -$0.77 in Q1 2025, and up 72.85% sequentially from -$4.03 in Q4 2025.
ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed EPS (Basic) across 11 years of filings, most recently posting -$1.09 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 41.18% year-over-year to -$1.09; the TTM figure through Mar 2026 stood at -$6.09 (up 65.25% YoY), while the FY2025 annual figure was -$8.93, up 84.32% from the prior year.
- EPS (Basic) improved to -$1.09 in Q1 2026, from -$4.03 in the prior quarter.
- Over the last five years, EPS (Basic) for NDRA reached as high as -$1.09 in Q1 2026 and fell as low as -$2323.6 in Q1 2022.
- The 5-year median for EPS (Basic) is -$401.38 (2023), against an average of -$727.79.
- Annual changes were most pronounced in 2022 — EPS (Basic) dropped 4.9% — and 2025, when it surged 99.59%.
- A 5-year view of EPS (Basic) shows it stood at -$1991.2 in 2022, then surged by 79.84% to -$401.38 in 2023, then jumped by 94.89% to -$20.53 in 2024, then soared by 80.38% to -$4.03 in 2025, then soared by 72.85% to -$1.09 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.09, -$4.03, and -$2.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 0.00 |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 4.45 |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 3.50 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -0.60 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 1.20 |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 0.84 |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 0.88 |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 8.35 |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | -1.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.09 |
| Dec 31, 2025 | -4.03 |
| Sep 30, 2025 | -2.10 |
| Mar 31, 2025 | -1.86 |
| Dec 31, 2024 | -20.53 |
| Sep 30, 2024 | -9.54 |
| Jun 30, 2024 | -142.99 |
| Mar 31, 2024 | -449.58 |
| Dec 31, 2023 | -401.41 |
| Sep 30, 2023 | -706.18 |
| Jun 30, 2023 | -746.39 |
| Mar 31, 2023 | -1,624.93 |
| Dec 31, 2022 | -1,991.28 |
| Sep 30, 2022 | -1,905.94 |
| Jun 30, 2022 | -2,039.22 |
| Mar 31, 2022 | -2,323.74 |
| Dec 31, 2021 | -2,655.80 |
| Sep 30, 2021 | -2,220.75 |
| Jun 30, 2021 | -2,686.07 |
| Mar 31, 2021 | -2,215.34 |